Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.2 USD -4.16% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
Research & Development

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Supernus Pharmaceuticals Inc
Research & Development Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive Research & Development Analysis
Latest Figures & CAGR of Competitors

Company Research & Development CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Research & Development
-$103.5m
CAGR 3-Years
-6%
CAGR 5-Years
-6%
CAGR 10-Years
-18%
Johnson & Johnson
NYSE:JNJ
Research & Development
-$16.4B
CAGR 3-Years
-5%
CAGR 5-Years
-8%
CAGR 10-Years
-7%
Bristol-Myers Squibb Co
NYSE:BMY
Research & Development
-$9.5B
CAGR 3-Years
1%
CAGR 5-Years
-13%
CAGR 10-Years
-10%
Pfizer Inc
NYSE:PFE
Research & Development
-$10.5B
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
-4%
Merck & Co Inc
NYSE:MRK
Research & Development
-$16B
CAGR 3-Years
-17%
CAGR 5-Years
-13%
CAGR 10-Years
-9%
Eli Lilly and Co
NYSE:LLY
Research & Development
-$10.5B
CAGR 3-Years
-15%
CAGR 5-Years
-14%
CAGR 10-Years
-8%

See Also

What is Supernus Pharmaceuticals Inc's Research & Development?
Research & Development
-103.5m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's Research & Development amounts to -103.5m USD.

What is Supernus Pharmaceuticals Inc's Research & Development growth rate?
Research & Development CAGR 10Y
-18%

Over the last year, the Research & Development growth was -20%. The average annual Research & Development growth rates for Supernus Pharmaceuticals Inc have been -6% over the past three years , -6% over the past five years , and -18% over the past ten years .

Back to Top